Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (5)

2006

  1. A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer, Vol. 16, Núm. 1, pp. 71-76

2005

  1. Assessment of the value of confirming responses in clinical trials in oncology

    European Journal of Cancer, Vol. 41, Núm. 11, pp. 1528-1532